Nanoparticle-Based Intracellular Delivery System of Immunomodulatory Agents for Initiation of an Anti-Tumor Immune Response
Fraught with chronic side effects, the current paradigm of cancer therapy includes chemotherapy and radiation. Advancements in nanomedical techniques have led to the emergence of a new field of research, cancer immunotherapy, which is the study of stimulating the human immune system to elicit an anti-tumor response through the proliferation of cytotoxic T lymphocytes (CTL) and, the more recently discovered killer dendritic cells.
